BioSpace News Archive

Older people who regularly walk, garden, swim or dance may have bigger brains than their inactive peers, according to a preliminary study to be presented at the American Academy of Neurology’s 72nd Annual Meeting in Toronto, Canada, April 25 to May 1, 2020.

Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare pediatric and orphan diseases, today announced that Jeff Wilkins, MD has joined the Company as its Chief Development Officer, with a specific focus on CERC-002, CERC-006 and CERC-007 clinical development programs.

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, based in Hyderabad India, received FDA approval for their generic version of Thiotepa 15mg and 100mg vials for injection.

BrainStorm Cell Therapeutics Inc., (NASDAQ: BCLI), a leading developer of cell technologies for neurodegenerative diseases, today announced that it has entered into a definitive agreement with Abbhi Investments, LLC, a healthcare-focused family office based in Miami, Florida, in connection with a privately negotiated sale of common stock and a warrant to purchase common stock (collectively, the “securities”).

On February 21, 2020 , the Government of Canada repatriated 129 Canadians who were on the Diamond Princess , which was docked in Japan following an outbreak of COVID-19, the illness caused by the novel coronavirus on board the cruise ship. Upon their return to Canada , these individuals were subject to a 14-day quarantine period and have been

In partnership with SpaceCells USA Inc. and BioServe Space Technologies, samples are scheduled for launch aboard the SpaceX CRS-20 cargo flight today

Starting today, SiriusXM channel 121 becomes “Coronavirus: What You Need To Know,” and will be available on both active and inactive SiriusXM radios, and on SiriusXM streaming platforms

Targets: Improve use and recycling of plastics and reduce usage of new plastic Cooperation at the European level

AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an agreement with Brigham and Women’s Hospital for an investigator-initiated study led by Richard D. Urman MD, MBA,

Procter & Gamble requests that their press release NewsItemId: 20200302005123 (issued March 2, 2020) “Herbal Essences Announces Commitment to Help Mitigate Biodiversity Loss” be killed.